🛒 Buy Online Hemlibra Emicizumab 30mg/ml Injection – Global Supply Saudi Arabia - Riyadh, Jeddah, Mecca, Medina, Dammam, USA, UK, UAE Australia, Europe, United Kingdom, United States, Cambridge, London, Morocco, Indonesia, Chile, Peru, Ethiopia, Romania, China, Japan, Russia, Ukraine, Dubai, United Arab Emirates, South Korea, Africa, Thailand, Vietnam, Middle East, and Southeast Asian countries.

💉 Hemlibra Emicizumab 30mg/ml Injection

🔷 Introduction

Hemlibra (Emicizumab 30mg/ml Injection) is a revolutionary treatment used primarily for patients with Hemophilia A, a rare genetic bleeding disorder. It is a bispecific monoclonal antibody that helps restore the blood clotting process, significantly reducing bleeding episodes in patients with or without factor VIII inhibitors.

🔬 Composition & Content

Active Ingredient: Emicizumab
Strength: 30 mg/mL
Form: Sterile solution for subcutaneous injection
Class: Bispecific monoclonal antibody

🧪 How it Works

Emicizumab mimics the function of factor VIII, a protein missing in Hemophilia A patients. It bridges activated factor IX and factor X, restoring the clotting cascade and preventing bleeding.

⚙️ Uses & Treatments

Hemlibra is mainly used in the treatment of:

Hemophilia A (with or without inhibitors)
Prevention of spontaneous bleeding episodes
Long-term prophylaxis therapy

💊 Dosage & Administration

📌 Recommended Dosing:

Loading Dose:
- 3 mg/kg once weekly for 4 weeks
Maintenance Dose (choose one):
- 1.5 mg/kg once weekly OR
- 3 mg/kg every 2 weeks OR
- 6 mg/kg every 4 weeks

📍 Administration:

Given as a subcutaneous injection (under the skin)
Injection sites: abdomen, thigh, or upper arm
Should be administered by a trained healthcare professional or caregiver

🧾 How to Use

Inspect the solution before use (clear to slightly yellow).
Use a sterile syringe for administration.
Rotate injection sites to avoid irritation.
Follow the dosing schedule strictly.

🌟 Advantages of Hemlibra

✔ Reduces frequency of bleeding episodes
✔ Convenient dosing (weekly or monthly)
✔ Effective in patients with inhibitors
✔ Improves quality of life
✔ Subcutaneous (less painful than IV therapy)

❄️ Storage Conditions

Store in a refrigerator at 2°C to 8°C
Do not freeze
Keep in original packaging to protect from light
Do not shake the vial
Can be kept at room temperature (below 30°C) for a limited time (as per guidelines)

🇮🇳 Alternative Indian Brands

Currently, Emicizumab is a highly specialized biologic, and Hemlibra by Roche is the primary globally recognized brand.

However, access alternatives may include:

Imported biosimilars (limited availability)
Factor VIII replacement therapies (as alternative treatment approach):
- Octocog alfa brands
- Recombinant factor VIII injections

⚠️ Note: True Indian biosimilar alternatives for Emicizumab are still limited due to complex manufacturing.

🧠 Conclusion

Hemlibra (Emicizumab) represents a major breakthrough in Hemophilia A management, offering patients a safer, more convenient, and highly effective preventive therapy. Its long-acting nature and reduced need for frequent injections make it a preferred choice worldwide.